Bacteriophages as potential new therapeutics to replace or supplement antibiotics (Q37784558)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 31, 2010

edit

Language	Label	Description	Also known as
English	Bacteriophages as potential new therapeutics to replace or supplement antibiotics	scientific article published on August 31, 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

title

Bacteriophages as potential new therapeutics to replace or supplement antibiotics (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

main subject

antibiotic

0 references

bacteriophage

1 reference

based on heuristic

inferred from title

author name string

Mzia Kutateladze

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

Revaz Adamia

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

20810181

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20810181

retrieved

4 July 2024

publication date

31 August 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S016777991000137X?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

https://api.elsevier.com/content/article/PII:S016777991000137X?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

published in

Trends in Biotechnology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

page(s)

591-595

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

cites work

Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Vancomycin-resistant enterococci: mechanisms and clinical observations

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Phage choice, isolation, and preparation for phage therapy.

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Designing phage therapeutics

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

STAPHAGE LYSATE THERAPY IN CHRONIC STAPHYLOCOCCAL INFECTIONS

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Phage therapy experience at the Eliava Institute

series ordinal

25

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Bacteriophage therapy

series ordinal

27

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Phage Therapy in Clinical Practice: Treatment of Human Infections

series ordinal

31

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth

series ordinal

32

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

series ordinal

33

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

series ordinal

34

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases

series ordinal

37

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Preventive value of dried dysentery bacteriophage

series ordinal

38

1 reference

stated in

Crossref

DOI

10.1016/J.TIBTECH.2010.08.001

reference URL

https://api.crossref.org/works/10.1016/J.TIBTECH.2010.08.001

retrieved

4 July 2024

Identifiers

DOI

10.1016/J.TIBTECH.2010.08.001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

PubMed publication ID

20810181

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20810181

retrieved

23 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37784558&oldid=2195608461"